» Articles » PMID: 35740385

Chronic Rhinosinusitis, Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity

Overview
Journal Biomedicines
Date 2022 Jun 24
PMID 35740385
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic rhinosinusitis (CRS) is a persistent inflammation of the nasal cavity and paranasal sinuses associated with tissue remodelling, dysfunction of the sinuses' natural defence mechanisms, and induction of different inflammatory clusters. The etiopathogenesis of CRS remains elusive, and both environmental factors, such as bacterial biofilms and the host's general condition, are thought to play a role. Bacterial biofilms have significant clinical relevance due to their potential to cause resistance to antimicrobial therapy and host defenses. Despite substantial medical advances, some CRS patients suffer from recalcitrant disease that is unresponsive to medical and surgical treatments. Those patients often have nasal polyps with tissue eosinophilia, -dominant mucosal biofilm, comorbid asthma, and a severely compromised quality of life. This review aims to summarise the contemporary knowledge of inflammatory cells/pathways in CRS, the role of bacterial biofilm, and their impact on the severity of the disease. Here, an emphasis is placed on biofilm and its secreted products. A better understanding of these factors might offer important diagnostic and therapeutic perceptions for recalcitrant disease.

Citing Articles

Hub genes, diagnostic model, and predicted drugs related to ferroptosis in chronic rhinosinusitis with nasal polyps.

Guo Q, Dong D, Qiao X, Huang S, Zhao Y Medicine (Baltimore). 2024; 103(48):e40624.

PMID: 39612457 PMC: 11608670. DOI: 10.1097/MD.0000000000040624.


Hops bitter β-acids have antibacterial effects against sinonasal Staphylococcus aureus but also induce sinonasal cilia and mitochondrial dysfunction.

Kouakou Y, Thompson J, Tan L, Miller Z, Ma R, Adappa N Int Forum Allergy Rhinol. 2024; 15(3):287-302.

PMID: 39533961 PMC: 11872787. DOI: 10.1002/alr.23487.


Sustained co-release of ciprofloxacin and dexamethasone in rabbit maxillary sinus using polyvinyl alcohol-based hydrogel microparticle.

Jalessi M, Moghaddam Y, Khanmohammadi M, Hassanzadeh S, Azad Z, Farhadi M J Mater Sci Mater Med. 2024; 35(1):60.

PMID: 39348071 PMC: 11442669. DOI: 10.1007/s10856-024-06832-9.


Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis.

Huang F, Liu F, Zhen X, Gong S, Chen W, Song Z Microorganisms. 2024; 12(8).

PMID: 39203531 PMC: 11357447. DOI: 10.3390/microorganisms12081690.


A Comprehensive Review on Biofilms in Otorhinolaryngology: Understanding the Pathogenesis, Diagnosis, and Treatment Strategies.

Ghosh Moulic A, Deshmukh P, Gaurkar S Cureus. 2024; 16(4):e57634.

PMID: 38707023 PMC: 11070220. DOI: 10.7759/cureus.57634.


References
1.
Poddighe D, Vangelista L . Infection and Persistence in Chronic Rhinosinusitis: Focus on Leukocidin ED. Toxins (Basel). 2020; 12(11). PMC: 7692112. DOI: 10.3390/toxins12110678. View

2.
Hayes S, Howlin R, Johnston D, Webb J, Clarke S, Stoodley P . Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: A novel observation. J Allergy Clin Immunol. 2015; 135(6):1648-51. DOI: 10.1016/j.jaci.2014.12.1929. View

3.
Mahdavinia M, Carter R, Ocampo C, Stevens W, Kato A, Tan B . Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. J Allergy Clin Immunol. 2014; 133(6):1759-63. PMC: 4040310. DOI: 10.1016/j.jaci.2013.12.1092. View

4.
Prince A, Steiger J, Khalid A, Dogrhamji L, Reger C, Eau Claire S . Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol. 2008; 22(3):239-45. DOI: 10.2500/ajr.2008.22.3180. View

5.
Costerton J, Lewandowski Z, Caldwell D, Korber D, Lappin-Scott H . Microbial biofilms. Annu Rev Microbiol. 1995; 49:711-45. DOI: 10.1146/annurev.mi.49.100195.003431. View